American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.
复制标题
DOI：
10.1016/j.brachy.2011.07.002
复制
发表时间：
2012-01
期刊：
影响因子：
1.9
通讯作者：
Erickson, Beth
中科院分区：
文献类型：
--
作者：
Viswanathan, Akila N.;Beriwal, Sushil;De Los Santos, Jennifer F.;Demanes, D. Jeffrey;Gaffney, David;Hansen, Jorgen;Jones, Ellen;Kirisits, Christian;Thomadsen, Bruce;Erickson, Beth
本报告介绍了2011年美国近距离放射治疗协会（ABS）局部晚期宫颈癌高剂量率（HDR）近距离放射治疗指南的更新。根据文献中的医学证据和妇科近距离放射治疗临床专家的意见，美国近距离放射治疗协会（ABS）的成员在宫颈癌近距离放射治疗方面具有专业知识，他们制定了使用串联和环形、卵形、圆柱形或间质性施源器进行局部晚期宫颈癌HDR近距离放射治疗的更新指南。宫颈癌指南制定委员会肯定了串联近距离放射治疗在局部晚期宫颈癌管理中的重要治疗作用。正确的施源器选择、插入和成像是手术的基本方面。利用磁共振或计算机断层扫描或放射摄影成像的三维成像可用于治疗计划。每次插入后，必须在治疗输送前进行剂量测定。必须记录施源器放置、剂量规格和剂量分次，必须执行质量保证措施，并且必须获得随访信息。存在用于整合近距离放射治疗与外部射束辐射的各种剂量/分次方案和方法。根据近距离放射治疗时的肿瘤大小，推荐的肿瘤剂量为80-90戈伊（2戈瑞（戈伊）/放射生物等效剂量（EQD 2））。正常组织的剂量限制进行了讨论。这些指南更新了2000年的指南，并提供了2011年HDR宫颈癌近距离放射治疗的全面描述。
This report presents the 2011 update to the American Brachytherapy Society (ABS) high-dose-rate (HDR) brachytherapy guidelines for locally advanced cervical cancer. Members of the American Brachytherapy Society (ABS) with expertise in cervical cancer brachytherapy formulated updated guidelines for HDR brachytherapy using tandem and ring, ovoids, cylinder or interstitial applicators for locally advanced cervical cancer were revised based on medical evidence in the literature and input of clinical experts in gynecologic brachytherapy. The Cervical Cancer Committee for Guideline Development affirms the essential curative role of tandem-based brachytherapy in the management of locally advanced cervical cancer. Proper applicator selection, insertion, and imaging are fundamental aspects of the procedure. Three-dimensional imaging with magnetic resonance or computed tomography or radiographic imaging may be used for treatment planning. Dosimetry must be performed after each insertion prior to treatment delivery. Applicator placement, dose specification and dose fractionation must be documented, quality assurance measures must be performed, and follow-up information must be obtained. A variety of dose/fractionation schedules and methods for integrating brachytherapy with external-beam radiation exist. The recommended tumor dose in 2 Gray (Gy) per fraction radiobiologic equivalence (EQD2) is 80–90 Gy, depending on tumor size at the time of brachytherapy. Dose limits for normal tissues are discussed. These guidelines update those of 2000 and provide a comprehensive description of HDR cervical cancer brachytherapy in 2011.
登录
查看更多内容
DOI：
10.1016/j.ijrobp.2009.11.002
发表时间：
2011-02-01
影响因子：
7
作者：
Georg, Petra;Lang, Stefan;Poetter, Richard
通讯作者：
Poetter, Richard
DOI：
10.1016/j.ijrobp.2004.01.034
发表时间：
2004-08-01
影响因子：
7
作者：
Lertsanguansinchai, P;Lertbutsayanukul, C;Charoonsantikul, C
通讯作者：
Charoonsantikul, C
DOI：
10.1016/0360-3016(94)00635-x
发表时间：
1995-07-30
影响因子：
7
作者：
PETEREIT, DG;SARKARIA, JN;BUCHLER, DA
通讯作者：
BUCHLER, DA
影响因子：
6.2
作者：
Hareyama, M;Sakata, K;Koito, K
通讯作者：
Koito, K
DOI：
10.1016/j.ijrobp.2008.10.033
发表时间：
2009-09-01
影响因子：
7
作者：
Dimopoulos, Johannes C. A.;Lang, Stefan;Poetter, Richard
通讯作者：
Poetter, Richard